Integer Holdings (ITGR)
(Delayed Data from NYSE)
$109.58 USD
-1.57 (-1.41%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $109.61 +0.03 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Integer (ITGR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$124.86 | $139.00 | $100.00 | 12.33% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Integer comes to $124.86. The forecasts range from a low of $100.00 to a high of $139.00. The average price target represents an increase of 12.33% from the last closing price of $111.15.
Analyst Price Targets (7 )
Broker Rating
Integer currently has an average brokerage recommendation (ABR) of 1.71 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, four are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 57.14% and 14.29% of all recommendations. A month ago, Strong Buy made up 42.86%, while Buy represented 14.29%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 3 | 3 | 2 |
Buy | 1 | 1 | 1 | 0 | 0 |
Hold | 2 | 2 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.71 | 1.71 | 2.00 | 2.00 | 2.20 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/9/2024 | KeyBanc Capital Markets | Brett Fishbin | Strong Buy | Strong Buy |
3/28/2024 | The Benchmark Company | Robert Wasserman | Strong Buy | Strong Buy |
3/14/2024 | C.L. King & Associates | Kristen M Stewart | Not Available | Moderate Buy |
2/23/2024 | Piper Sandler | Matthew O'Brien | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.71 |
ABR (Last week) | 1.71 |
# of Recs in ABR | 7 |
Average Target Price | $124.86 |
LT Growth Rate | 13.60% |
Industry | Medical - Instruments |
Industry Rank by ABR | 86 of 252 |
Current Quarter EPS Est: | 1.24 |